TipRanks
pc:enare

ENA Respiratory

31 Queen Street Melbourne, Victoria 3000, AU
https://enarespiratory.com/
ENA Respiratory is a clinical-stage pharmaceutical company tackling respiratory viral infections through the development of host defense enhancers which locally prime and boost the body's natural first line of defense against invading pathogens. Being virus-agnostic, ENA's approach offers a solution to protect against common and emerging respiratory viruses for which vaccines or direct-acting antivirals have limitations or do not exist.

Leadership & Board

Current Number of Employees10
Current LinkedIn Followers1,513

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$22M
Total Amount Raised$22M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$22M
Latest Funding Amount$22M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―

Employee Trend

ENA Respiratory had 10 employees as of September 28, 2026. The number of employees increased by 0 (0.00%) week-over-week.
10Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

ENA Respiratory had 1,513 followers as of September 28, 2026. The number of followers increased by 14 (0.93%) week-over-week.
1,513Latest Followers Count
14(0.93%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Oct 22, 2025
Series B
$22.40M
―

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to ENA Respiratory, helping you discover and navigate related company profiles.

Related News and Analysis